Technical Analysis on Application Software Equities -- Oracle, Mobileye, Allscripts Healthcare Solutions, RingCentral, and Synchronoss Technologies

Jul 15, 2015, 09:10 ET from

NEW YORK, July 15, 2015 /PRNewswire/ --

Equity Research Institute has initiated coverage on the following equities: Oracle Corporation (NYSE: ORCL), Mobileye N.V. (NYSE: MBLY), Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX), RingCentral Inc. (NYSE: RNG), and Synchronoss Technologies Inc. (NASDAQ: SNCR). Free research report on Oracle can be accessed at On Tuesday, July 14, 2015, the NASDAQ Composite ended at 5,104.89, up 0.66%, the Dow Jones Industrial Average advanced 0.42%, to finish the day at 18,053.58, and the S&P 500 closed at 2,108.95, up 0.45%. The gains were broad based as seven out of nine sectors ended the session in positive. Register for your complimentary reports at the links given below.  

On Tuesday, shares in Oracle Corp. ended the session 0.05% lower at $40.78. The stock reported a trading volume of 9.30 million shares, below its three months average volume of 14.57 million shares. Shares of the company traded at a PE ratio of 18.45. Oracle Corp.'s shares have declined 7.69% in the last one month, 4.21% in the previous three months and 8.41% on YTD basis. The company is trading 4.57% below its 50-day moving average and 2.90% below its 200-day moving average. Moreover, shares of Oracle Corp. have a Relative Strength Index (RSI) of 41.40. Sign up and read the free notes on ORCL at:

Mobileye N.V.'s stock edged 0.94% higher, to close the day at $58.99. The stock recorded a trading volume of 3.91 million shares, above its three months average volume of 3.42 million shares. Over the last one month and over the past three months, Mobileye N.V.'s shares have gained 14.41% and 39.29%, respectively. Furthermore, the stock has surged 45.44% since the start of this year. The company's shares are trading 18.26% above their 50-day moving average and 30.82% above their 200-day moving average. Additionally, Mobileye N.V. has an RSI of 69.79. The complimentary notes on MBLY can be downloaded in PDF format at:

On Tuesday, shares in Allscripts Healthcare Solutions Inc. recorded a trading volume of 1.73 million shares, lower than their three months average volume of 3.04 million shares. The stock ended the day 1.57% higher at $13.56. Although Allscripts Healthcare Solutions Inc.'s stock has lost 4.17% in the last one month, it has advanced 11.79% in the previous three months and 6.19% on YTD basis. The company is trading above its 200-day moving average by 5.47%. Furthermore, shares of Allscripts Healthcare Solutions Inc. have an RSI of 45.66. Register for free on Equity Research Institute and access the latest research on MDRX at:

RingCentral Inc.'s stock edged 0.06% lower, to close Tuesday's session at $17.51. The stock recorded a trading volume of 0.65 million shares, above its three months average volume of 0.53 million shares. Over the previous three months and since the beginning of 2015, RingCentral Inc.'s shares have advanced 3.06% and 17.36%, respectively. However, the stock has lost 2.88% in the last one month. The company is trading 16.44% above its 200-day moving average. Furthermore, RingCentral Inc.'s stock has an RSI of 45.39. The complete research on RNG is available for free at:

Synchronoss Technologies Inc.'s stock finished Tuesday's session 1.42% higher at $46.44. A total of 0.57 million shares were traded, which was above its three months average volume of 0.50 million shares. Over the last one month and the previous three months, Synchronoss Technologies Inc.'s shares have fallen by 3.41% and 6.93%, respectively. However, the stock has gained 10.94% on YTD basis. The company's shares are trading above their 200-day moving average by 2.01%. Synchronoss Technologies Inc.'s stock traded at a PE ratio of 49.94 and has an RSI of 45.75. Free in-depth research on SNCR is available at:


About Equity Research Institute: 

Equity Research Institute ("ERI") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ERI has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ERI has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the CFA® have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the CFA® (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.


ERI, the Author, the Reviewer and the CFA® (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ERI nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


ERI is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia. Do not send email to robottrap (at)

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.